Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in Plaque Psoriasis
NCT00244842Phase 3Completed
- Sponsor
- Aurinia
- Start
- Dec 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of voclosporin in plaque psoriasis (4 arms), sponsored by Aurinia. Primary endpoint: Proportion of Subjects Achieving a PASI-75 at 12 weeks. Started Dec 2004; status: completed.
02
Drugs
voclosporin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00244842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244842.